rs35500644
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000567.3(CRP):c.105T>G(p.Thr35Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00105 in 1,613,238 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 11 hom., cov: 31)
Exomes 𝑓: 0.00057 ( 8 hom. )
Consequence
CRP
NM_000567.3 synonymous
NM_000567.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00300
Publications
1 publications found
Genes affected
CRP (HGNC:2367): (C-reactive protein) The protein encoded by this gene belongs to the pentraxin family which also includes serum amyloid P component protein and pentraxin 3. Pentraxins are involved in complement activation and amplification via communication with complement initiation pattern recognition molecules, but also complement regulation via recruitment of complement regulators. The encoded protein has a calcium dependent ligand binding domain with a distinctive flattened beta-jellyroll structure. It exists in two forms as either a pentamer in circulation or as a nonsoluble monomer in tissues. It is involved in several host defense related functions based on its ability to recognize foreign pathogens and damaged cells of the host and to initiate their elimination by interacting with humoral and cellular effector systems in the blood. Consequently, the level of this protein in plasma increases greatly during acute phase response to tissue injury, infection, or other inflammatory stimuli. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-159714095-A-C is Benign according to our data. Variant chr1-159714095-A-C is described in ClinVar as Benign. ClinVar VariationId is 709552.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.003 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00564 (858/152262) while in subpopulation AFR AF = 0.0197 (820/41536). AF 95% confidence interval is 0.0186. There are 11 homozygotes in GnomAd4. There are 418 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRP | NM_000567.3 | c.105T>G | p.Thr35Thr | synonymous_variant | Exon 2 of 2 | ENST00000255030.9 | NP_000558.2 | |
| CRP | NM_001329057.2 | c.105T>G | p.Thr35Thr | synonymous_variant | Exon 2 of 3 | NP_001315986.1 | ||
| CRP | NM_001382703.1 | c.105T>G | p.Thr35Thr | synonymous_variant | Exon 2 of 3 | NP_001369632.1 | ||
| CRP | NM_001329058.2 | c.105T>G | p.Thr35Thr | synonymous_variant | Exon 2 of 4 | NP_001315987.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00563 AC: 856AN: 152144Hom.: 11 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
856
AN:
152144
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00137 AC: 339AN: 248090 AF XY: 0.00111 show subpopulations
GnomAD2 exomes
AF:
AC:
339
AN:
248090
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000567 AC: 828AN: 1460976Hom.: 8 Cov.: 31 AF XY: 0.000517 AC XY: 376AN XY: 726880 show subpopulations
GnomAD4 exome
AF:
AC:
828
AN:
1460976
Hom.:
Cov.:
31
AF XY:
AC XY:
376
AN XY:
726880
show subpopulations
African (AFR)
AF:
AC:
664
AN:
33468
American (AMR)
AF:
AC:
32
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26114
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
11
AN:
86240
European-Finnish (FIN)
AF:
AC:
0
AN:
52650
Middle Eastern (MID)
AF:
AC:
16
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
27
AN:
1111964
Other (OTH)
AF:
AC:
78
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00564 AC: 858AN: 152262Hom.: 11 Cov.: 31 AF XY: 0.00561 AC XY: 418AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
858
AN:
152262
Hom.:
Cov.:
31
AF XY:
AC XY:
418
AN XY:
74474
show subpopulations
African (AFR)
AF:
AC:
820
AN:
41536
American (AMR)
AF:
AC:
28
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68024
Other (OTH)
AF:
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
47
94
141
188
235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 07, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.